Mr Info

ok, that did it. Van Williams

I am bummed about not being able to travel to Buffalo and be at the stadium. But...I may be more excited for the opener than in other years. With no preseason and limited media at camp, I have no idea what to expect. It does appear the Bills have a good strategy to limit infections at camp. It will be interesting to see how much impact that Bills’ planning and preparation (Beane acquiring Diggs rather than acclimating a rookie WR; sending rookies to their local residence early at camp, etc.) for this unusual season have on game performance.

Does anyone have an answer for this? Why is Type 2 diabetes an opt out but not Type 1? This came from the CDC.

https://www.foxnews.com/health/man-penis-infection-arm This presents so many possibilities.

I will be listening to ‘72 Wembley Empire Pool as that was on my bday. @Logicis there a ‘He’s Gone’ from any show that stands out for you?

His wife had stage 3 Hodgkins lymphoma that went into remission last year. https://www.google.com/amp/s/billswire.usatoday.com/2019/09/11/buffalo-bills-kyle-peko-wife-is-cancer-free/amp/

@sherpa & @apuszczalowski - thx for feedback I obtained 1 quote for solar & waiting on another from established companies. We live in an historic area so do not want visible panels on the house. It ends up the far side of the garage (facing away from the house and not visible) is south facing with no shade so that is where the panels would be placed. Payback would be ~10 yrs based on calculations for current kWa consumption & reduction from solar. Prob going to do it due to Solar Fed Tax Credit of 26% this year which changes to 22% next year and disappears in 2022. Getting two quotes for geothermal system next week. This would replace current HVAC systems. Plan to use existing duct work and will ask if current hvac fans can remain. Expect this will have to be a vertical install which will make it expensive so may wait until next year and leverage the tax credit solar system this year.. A geothermal system will reduce energy consumption so the solar payback will be extended by a few years. But the solar system we are considering is ~33% of our energy consumption and geothermal may double that by reducing our overall consumption but still below 100%. No reason to give free power to the grid.

So...has anyone taken pics of the Bills video boards to post here showing this?

TBDers, Interested in any feedback on geothermal and/or solar systems at your house. Specifically: installation, ROI/payback, durability, & maintenance. thx

From that cliff city is the 187 step King of Aragon staircase that was hewn into the limestone to descend to the sea.

Fave vacation spot is Corsica. Making plans to return next year. This is sunset behind the town of Bonifacio.

Eek! I thought that was Babe Ruth on the left.

Yes https://www.espn.com/nfl/story/_/id/22836078/john-brown-baltimore-ravens-says-sickle-cell-affecting-health

Sickle cell is covered but not sickle cell trait. The trait, in simple terms, means 1 parent had sickle cell gene and the other did not. https://www.nhlbi.nih.gov/news/2010/questions-and-answers-about-sickle-cell-trait

You are correct...good memory. But having the trait is not identified as an opt-out. https://www.espn.com/nfl/story/_/id/22836078/john-brown-baltimore-ravens-says-sickle-cell-affecting-health

also being evaluated at airports so this may be a possibility. https://www.google.com/amp/s/www.cnn.com/travel/amp/airport-dogs-trial-coronavirus-wellness/index.html

There is a vaccine, Shingrix, for Shingles which was approved in 2017 and more effective than its predecessor, Zostavax, which was approved in 2006.

This is nothing new depending on the state you live in. For example in VA: “For the mixed beverage licensee, current Virginia ABC regulations stipulate that a minimum 45 percent of the total gross sales must be from food and nonalcoholic beverages. Conversely, alcohol sales should comprise no more than 55 percent of these sales.”

Imo, the # of deaths should not be the basis if you are trying to perform a comparison. The data should also include the # of people hospitalized and those in ICU/ventilators for a C19 impact analysis. So far, I have had a close friend and an acquaintance who were both in ICU & on ventilators for over 12 days. One even had a tracheostomy. Many of us thought neither would make it but thankfully both are now home. Just comparing C19 deaths against flu deaths in other years without including the impact to the medical community to treat C19 patients and prevent death would not encompass the full impact of C19.

Moderna early vaccine results reported this morning in CNBC article summarizing NEJM publication late yesterday...all great news. https://www.cnbc.com/2020/07/14/moderna-says-its-coronavirus-vaccine-trial-produced-robust-immune-response-in-all-patients.html Moderna's potential vaccine to prevent Covid-19 produced neutralizing antibodies in all 45 patients in its early stage human trial, according to newly released data. The findings provide more promising data that the vaccine may give some protection against the coronavirus. Moderna's shares soared after the company said its potential vaccine to prevent Covid-19 produced a "robust" immune response in all 45 patients in its early stage human trial, according to newly released data published Tuesday evening in the peer-reviewed New England Journal of Medicine. All 45 patients produced neutralizing antibodies, which scientists believe is important for building immunity and provided more promising data that the vaccine may give some protection against the coronavirus. In the trial, each participant received a 25, 100 or 250 microgram dose, with 15 people in each dose group. Participants received two doses of the potential vaccine. After two vaccinations, the vaccine elicited a "robust" immune response in all participants in all dose cohorts, Moderna said. The company said the levels of neutralizing antibodies in patients in the high dose group were fourfold higher than in recovered Covid-19 patients. "These Phase 1 data demonstrate that vaccination with mRNA-1273 elicits a robust immune response across all dose levels and clearly support the choice of 100 µg in a prime and boost regimen as the optimal dose for the Phase 3 study," Moderna's chief medical officer, Tal Zaks, said in a statement. "We look forward to beginning our Phase 3 study of mRNA-1273 this month to demonstrate our vaccine's ability to significantly reduce the risk of COVID-19 disease." In May, the company had released preliminary information from its early stage trial, but it lacked all of its data and it hadn't been peer-reviewed yet. Moderna said the vaccine was generally well tolerated, but more than half of the participants reported mild or moderate symptoms such as fatigue, muscle aches or pain at the injection site. Evaluation of the durability of immune responses is ongoing, Moderna said, and participants will be followed for one year after the second vaccination. The effort by Moderna is one of several working on a potential vaccine for Covid-19, which has infected more than 13 million people and killed at least 573,200 across the globe as of Tuesday, according to data compiled by Johns Hopkins University. More than 100 vaccines are under development globally, according to the World Health Organization. Earlier Tuesday, Moderna announced it would begin its late-stage trial for its vaccine on July 27. The trial will enroll 30,000 participants across 87 locations, according to ClinicalTrials.gov. Participants in the experimental arm will receive a 100 microgram dose of the potential vaccine on the first day and another 29 days later. Some patients will also receive a placebo. Moderna's experimental vaccine contains genetic material called messenger RNA, or mRNA. The mRNA is a genetic code that tells cells what to build — in this case, an antigen that may induce an immune response to the virus. It became the first candidate to enter a phase 1 human trial in March. Scientists are still learning about key aspects of the virus, including how immune systems respond once a person is exposed. The answers, they say, may have important implications for vaccine development, including how quickly it can be deployed to the public. The U.S. is aiming to deliver 300 million doses of a vaccine for Covid-19 by early 2021. [Edit: here's the NEJM article, finally. https://www.nejm.org/doi/full/10.1056/NEJMoa2022483?query=featured_home A key figure for neutralizing antibodies:

It’s the real name of a guy I met in college but still the best I ever heard. Richard ‘Dick’ Weiner.

I posted about a flight I made ~mid-June a couple of pages back: RT: RIC-IAD-BUF. After my June experience, I flew the first part of the same trip yesterday. Planes were about 50% full. I was able to reserve single row seats on all flights. Everyone I saw wore masks on the flights and in the terminals unless they were eating or drinking. I remain more comfortable flying than going to a Lowe’s/Home Depot. Unsure how long the enforcement/compliance with face coverings & distancing (e.g., ingress & egress to the planes are managed well) for air travel will continue along with the paucity of passengers at airports.

Garcia

This has been the only published article, thus far, correlating the spread of C19 and air conditioners. It would lend more credence if another peer-reviewed paper were published corroborating this. There is this article questioning its conclusion. https://www.healthline.com/health-news/can-air-conditioning-spread-covid-19-probably-not This article uses expert opinion to dismiss but no evidence. Would like to see more data to support this type of transmission than the one paper.